SCHEMBL4554020

SCHEMBL4554020

O=S(=O)(c1ccc(F)cc1F)N1CCCCCC1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.61
TSHR P16473 6/20 0.58
ALDH1A1 P00352 3/20 0.58
PKM P14618 3/20 0.57
MAPT P10636 2/20 0.57
PKLR P30613 1/20 0.57
CYP3A4 P08684 1/20 0.55
CYP2C9 P11712 1/20 0.55
CYP2C19 P33261 1/20 0.55
KMT2A Q03164 2/20 0.51
L3MBTL1 Q9Y468 2/20 0.50
HTT P42858 1/20 0.50
ALOX15 P16050 1/20 0.50
USP2 O75604 1/20 0.48
HTR2A P28223 1/20 0.48
HTR2C P28335 1/20 0.48
CNR1 P21554 1/20 0.48
NPC1 O15118 1/20 0.48
RAB9A P51151 1/20 0.48
MCOLN3 Q8TDD5 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20595150 1.00 KDM4E (0.61) KDM4ETSHRALDH1A1PKMMAPT
SCHEMBL4556004 0.86 PKM (0.71) KDM4ETSHRALDH1A1PKMMAPT
SCHEMBL28213830 0.83 PKM (0.54) TSHRALDH1A1PKMMAPTPKLR
SCHEMBL4578854 0.83 CNR1 (0.66) TSHRALDH1A1PKMMAPTPKLR
SCHEMBL29432528 0.83 PKM (0.54) KDM4ETSHRALDH1A1PKMMAPT
SCHEMBL25941353 0.83 ALDH1A1 (0.65) KDM4ETSHRALDH1A1PKMMAPT
SCHEMBL14501504 0.83 GAA (0.56) KDM4ETSHRALDH1A1MAPTCYP3A4
SCHEMBL24711308 0.81 HTR2A (0.53) TSHRALDH1A1PKMMAPTPKLR
SCHEMBL28254881 0.80 TSHR (0.55) KDM4ETSHRALDH1A1PKMMAPT
SCHEMBL4166290 0.80 ALDH1A1 (0.67) KDM4ETSHRALDH1A1MAPTL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2134714-A1 TRICYCLIC ISOQUINOLINE DERIVATIVES FOR TREATMENT OF OBESITY Biovitrum AB (publ) (SE) 2009-12-23 EP disclosed
WO-2008110598-A1 TRICYCLIC ISOQUINOLINE DERIVATIVES FOR TREATMENT OF OBESITY BIOVITRUM AB (PUBL) (SE) 2008-09-18 WO disclosed